Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBodycote Regulatory News (BOY)

Share Price Information for Bodycote (BOY)

Share Price is delayed by 15 minutes
Get Live Data
711.50    -7.50 (-1.04%)
Bid:
712.50
Ask:
714.00
Spread: 1.50 (0.211%)
Market Cap: £1.21b
BOY Live PriceLast checked at - London Stock Exchange

Intraday Bodycote Share Chart

Divisional re-statement for enhanced Optimise programme

18 Nov 2025 07:05

Bodycote Plc - Divisional re-statement for enhanced Optimise programme

Bodycote Plc - Divisional re-statement for enhanced Optimise programme

PR Newswire

LONDON, United Kingdom, November 18

18 November 2025

Bodycote plc

Divisional re-statement for enhanced Optimise programme

 

 

Bodycote, the world's leading provider of specialist thermal processing services, today publishes historical financial information for 2024 and the first half of 2025 reflecting a new divisional reporting structure.

 

At our Half Year results on 30 July 2025 we announced an expansion to the scope of our ongoing Optimise programme. The revised and final programme, which includes 30 plants, will deliver an improved run-rate profit benefit of at least £15m by mid-2027 for a net cash cost of £10-15m. As a result of this expanded scope, the additional plants will now be classified as Non-Core. Our Full Year 2025 results will be presented based on this updated structure.

 

The tables below show our H1 2024, FY 2024 and H1 2025 divisional performance on the new re-classified basis. The historical financial information contained in the following tables is unaudited.

 

 

Half year to 30 June 2025

Specialist Technologies

Precision Heat Treatment

Central costs and eliminations

Total Core

Non-Core

Total Group

£m

£m

£m

£m

£m

£m

Revenue

104.5

232.1

-

336.6

32.4

369.0

Adjusted operating profit/(loss)

27.2

34.9

(8.6)

53.5

1.6

55.1

Return on sales

26.0%

15.0%

 

15.9%

4.9%

14.9%

 

 

 

Half year to 30 June 2024

 

 

Specialist Technologies

Precision Heat Treatment

Central costs and eliminations

Total Core

Non-Core

Total Group

£m

£m

£m

£m

£m

£m

Revenue

115.3

243.0

-

358.3

40.7

399.0

Adjusted operating profit/(loss)

34.4

40.4

(10.2)

64.6

2.2

66.8

Return on sales

29.8%

16.6%

 

18.0%

5.4%

16.7%

 

 

 

2024 FY

 

 

Specialist Technologies

Precision Heat Treatment

Central costs and eliminations

Total Core

Non-Core

Total Group

£m

£m

£m

£m

£m

£m

Revenue

222.3

459.8

-

682.1

75.0

757.1

Adjusted operating profit/(loss)

65.5

80.4

(20.4)

125.5

3.5

129.0

Return on sales

29.5%

17.5%

 

18.4%

4.7%

17.0%

 

 

 

 

 

 

For further information, please contact:

 

Bodycote plc

Jim Fairbairn, Chief Executive Officer

Ben Fidler, Chief Financial Officer

Peter Lapthorn, Investor Relations and FP&A

Tel: +44 1625 505 300

 

Disclosures:

This announcement contains forward-looking statements based on current expectations and assumptions. Various known and unknown risks, uncertainties and other factors may cause actual results to differ from future results or developments expressed or implied from the forward-looking statements. Each forward-looking statement speaks only as of the date of this document. Bodycote plc accepts no obligation to revise or update these forward-looking statements publicly or adjust them to future events or developments, whether as a result of new information, future events or otherwise, except to the extent legally required.

 



Date   Source Headline
22nd Dec 20252:41 pmPRNHolding(s) in Company
22nd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amPRNTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amPRNTransaction in Own Shares
18th Dec 20253:32 pmRNSHolding(s) in Company
18th Dec 20253:32 pmPRNHolding(s) in Company
18th Dec 20257:00 amPRNTransaction in Own Shares
17th Dec 20257:00 amPRNTransaction in Own Shares
16th Dec 20257:00 amPRNTransaction in Own Shares
15th Dec 20257:00 amPRNTransaction in Own Shares
12th Dec 20253:00 pmPRNHolding(s) in Company
12th Dec 20257:00 amPRNTransaction in Own Shares
11th Dec 20257:00 amPRNTransaction in Own Shares
10th Dec 20257:00 amPRNTransaction in Own Shares
9th Dec 20257:00 amPRNTransaction in Own Shares
8th Dec 20257:00 amPRNTransaction in Own Shares
5th Dec 20257:00 amPRNTransaction in Own Shares
4th Dec 20257:00 amPRNTransaction in Own Shares
3rd Dec 20257:00 amPRNTransaction in Own Shares
2nd Dec 20257:00 amPRNTransaction in Own Shares
1st Dec 20257:00 amPRNTransaction in Own Shares
28th Nov 20257:00 amPRNTransaction in Own Shares
27th Nov 20257:00 amPRNTransaction in Own Shares
26th Nov 20257:00 amPRNTransaction in Own Shares
25th Nov 20257:00 amPRNTransaction in Own Shares
24th Nov 20257:00 amPRNTransaction in Own Shares
21st Nov 20257:00 amPRNTransaction in Own Shares
21st Nov 20257:00 amPRNCompletion of disposal of ten Non-Core sites in France
20th Nov 20257:00 amPRNTransaction in Own Shares
19th Nov 20257:00 amPRNTransaction in Own Shares
18th Nov 20257:15 amPRNTransaction in Own Shares
18th Nov 20257:05 amPRNDivisional re-statement for enhanced Optimise programme
18th Nov 20257:00 amPRNNovember Trading Update
17th Nov 20257:00 amPRNTransaction in Own Shares
14th Nov 20257:00 amPRNTransaction in Own Shares
13th Nov 20257:00 amPRNTransaction in Own Shares
12th Nov 20257:00 amPRNTransaction in Own Shares
11th Nov 20257:00 amPRNTransaction in Own Shares
10th Nov 20257:00 amPRNTransaction in Own Shares
7th Nov 20257:00 amPRNTransaction in Own Shares
6th Nov 20257:00 amPRNTransaction in Own Shares
5th Nov 20257:00 amPRNTransaction in Own Shares
4th Nov 20257:00 amPRNTransaction in Own Shares
3rd Nov 20257:00 amPRNTransaction in Own Shares
31st Oct 20257:00 amPRNTransaction in Own Shares
30th Oct 20257:00 amPRNTransaction in Own Shares
29th Oct 20257:00 amPRNTransaction in Own Shares
28th Oct 20257:00 amPRNTransaction in Own Shares
27th Oct 20257:00 amPRNTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.